

Bioexcel supports pharmaceutical manufacturers
Bioexcel supports pharmaceutical manufacturers in designing, justifying, and maintaining robust cleaning validation programs aligned with current regulatory expectations.
Our approach to cleaning validation is toxicology-driven and risk-based, ensuring scientifically justified acceptance limits, defensible worst-case selection, and documentation that stands up to regulatory inspections.
We help manufacturers manage cross-contamination risks in shared equipment and facilities while maintaining compliance with EMA guidance, EU GMP, and global regulatory standards.
WHAT WE SUPPORT
- HBEL / PDE-based cleaning acceptance limits
- Cross-contamination risk assessment
- Worst-case product and equipment selection
- Cleaning validation protocols and reports
- Inspection and audit readiness

Cleaning Validation Services
Alignment & Documentation
Regulatory & Guidance Alignment
Cleaning validation services are aligned with: – EMA guidance on HBEL and cross-contamination – EU GMP requirements – ICH Q9 (Quality Risk Management) – Toxicological risk assessment best practices
Integration with Pharma Compliance Activities
Built for Inspections and Audits
Cleaning validation outputs integrate with: – PDE, OEL & CLP (Pharma) – Nitrosamine Risk Assessment -Extractables & Leachables (Pharma)
This ensures consistent toxicological justification across all pharma compliance activities.
Who This Service Is For
- Pharmaceutical manufacturers
- API and formulation facilities
- Quality Assurance and Validation teams
- Companies operating shared equipment or facilities
Why Bioexcel
- Toxicology-driven cleaning validation expertise
- Regulator-aligned risk-based approach
- Inspection-ready documentation
- Clear separation from medical device validation activities
Build Defensible Cleaning Validation Programs
Bioexcel helps pharmaceutical companies implement cleaning validation strategies that are scientifically justified, regulator-aligned, and inspection-ready.








